-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J6CHgk6xhI20OLSxeO32LSHf3ZqARqLDuu8NhtdvFCOQt3JluI2OeYqdhEc8DIBH k/IV2trFER5IKRCOmuOjYw== 0001231977-07-000029.txt : 20070509 0001231977-07-000029.hdr.sgml : 20070509 20070509162919 ACCESSION NUMBER: 0001231977-07-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070508 FILED AS OF DATE: 20070509 DATE AS OF CHANGE: 20070509 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KEISER DAVID W CENTRAL INDEX KEY: 0001231953 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 07832858 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-05-08 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231953 KEISER DAVID W C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 President & COO Common Stock, par value $.0001 per share 2007-05-08 4 M 0 9375 10.5 A 114793 D Common Stock, par value $.0001 per share 2007-05-08 4 S 0 9375 47 D 105418 D Option to Purchase Common Stock, par value $.0001 per share 10.5 2007-05-08 4 M 0 9375 0 D 1997-07-31 2007-07-31 Common Stock, par value $.0001 per share 9375 9375 D The sales reported by this Form 4 are made pursuant to the terms of a Sales Plan designed to meet the requirements of Rule 10b5-1 (c) (1) of the Securities Exchange Act. /s/ David Keiser 2007-05-09 -----END PRIVACY-ENHANCED MESSAGE-----